Cinacalcet hydrochloride
Cinacalcet hydrochloride (/sɪnəˈkælsɛt ˈhaɪdrəˌklaɪd/) is a medication used primarily in the treatment of hyperparathyroidism, a condition characterized by an overactive parathyroid gland. It is also used in the management of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis.
Etymology
The name "Cinacalcet" is derived from its chemical structure. The prefix "Cina-" is derived from the Latin word for "cinchona", a type of tree from which quinine, a treatment for malaria, is derived. The suffix "-calcet" is derived from the Latin word "calx", meaning "lime" or "limestone", which is a reference to the drug's effect on calcium levels in the body.
Pharmacology
Cinacalcet hydrochloride is a calcimimetic agent that increases the sensitivity of the calcium-sensing receptor (CaSR) to extracellular calcium. This results in a decrease in parathyroid hormone (PTH) levels, which in turn reduces serum calcium levels.
Related Terms
- Hyperparathyroidism
- Secondary hyperparathyroidism
- Chronic kidney disease
- Calcimimetic
- Calcium-sensing receptor
- Parathyroid hormone
See Also
External links
- Medical encyclopedia article on Cinacalcet hydrochloride
- Wikipedia's article - Cinacalcet hydrochloride
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski